We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
-14.08%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$49.9B
AUM Growth
-$4.08B
Cap. Flow
+$2.86B
Cap. Flow %
5.72%
Top 10 Hldgs %
51.45%
Holding
169
New
17
Increased
38
Reduced
75
Closed
24

Top Buys

Rank Stock Value
1
SONY icon
Sony
SONY
+$614M
2
AXP icon
American Express
AXP
+$273M
3
V icon
Visa
V
+$168M
4
CG icon
Carlyle Group
CG
+$123M
5
LRCX icon
Lam Research
LRCX
+$88.8M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$265M
2
QCOM icon
Qualcomm
QCOM
+$202M
3
PLAN
Anaplan, Inc.
PLAN
+$201M
4
MSFT icon
Microsoft
MSFT
+$181M
5
IT icon
Gartner
IT
+$160M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Consumer Discretionary 8.03%
3 Financials 5.66%
4 Communication Services 3.69%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCOR icon
126
Procore
PCOR
$8.84B
$15M 0.03%
258,121
-718,265
-74% -$45.7M
XMTR icon
127
Xometry
XMTR
$5.19B
$13.4M 0.03%
364,167
-9,533
-3% -$436K
ALTR
128
DELISTED
Altair Engineering Inc
ALTR
$12.7M 0.03%
197,146
-104,858
-35% -$6.61M
CRBU icon
129
Caribou Biosciences
CRBU
$165M
$11.2M 0.02%
1,223,549
-23,076
-2% -$243K
ORIC icon
130
Oric Pharmaceuticals
ORIC
$1.41B
$10.2M 0.02%
1,906,968
+480,000
+34% +$4.32M
ZM icon
131
Zoom
ZM
$31.4B
$8.91M 0.02%
76,000
STEM icon
132
Stem
STEM
$50.9M
$8.59M 0.02%
39,002
-998
-2% -$232K
KLRS
133
Kalaris Therapeutics
KLRS
$93.7M
$5.09M 0.01%
32,779
-526
-2% -$105K
MREO
134
Mereo BioPharma
MREO
$43.5M
$2.17M ﹤0.01%
1,935,600
ATVI
135
DELISTED
Activision Blizzard
ATVI
$2.04M ﹤0.01%
25,495
-1,019,955
-98% -$79.5M
TTWO icon
136
Take-Two Interactive
TTWO
$47.4B
$890K ﹤0.01%
5,787
-510,129
-99% -$81.6M
ANSS
137
DELISTED
Ansys
ANSS
-86,441
Closed -$34.7M
BILI icon
138
Bilibili
BILI
$7.95B
-633,450
Closed -$29.4M
COST icon
139
Costco
COST
$423B
-2,722
Closed -$1.54M
CRWD icon
140
CrowdStrike
CRWD
$229B
-300,000
Closed -$15.4M
DDOG icon
141
Datadog
DDOG
$93.6B
-58,915
Closed -$10.5M
KPTI icon
142
Karyopharm Therapeutics
KPTI
$44.4M
-130,773
Closed -$12.6M
MDB icon
143
MongoDB
MDB
$33.5B
-4,673
Closed -$2.47M
NGNE icon
144
Neurogene
NGNE
$729M
-11,247
Closed -$1.08M
NOW icon
145
ServiceNow
NOW
$132B
-176,855
Closed -$23M
OKTA icon
146
Okta
OKTA
$26.2B
-225,437
Closed -$50.5M
PDD icon
147
Pinduoduo
PDD
$132B
-1,003,470
Closed -$51.6M
PYPL icon
148
PayPal
PYPL
$50.5B
-946,284
Closed -$126M
SHOP icon
149
CALL
Shopify
SHOP
$200B
-2,375,000
Closed -$327M
TAL icon
150
TAL Education Group
TAL
$6.93B
-1,500,000
Closed -$5.89M

Similar funds

Alkeon Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Alkeon Capital Management held 169 positions worth $49.9B, down 7.6% from $54B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Alkeon Capital Management deployed $2.86B of net new capital in Q1 2022, opening 17 new positions and adding to 38 existing holdings. Its largest new stake was American Express: 1,512,619 shares worth $283M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $265M trimmed.

  • Alkeon Capital Management's largest Q1 2022 buy was American Express: 1,512,619 shares worth $283M.
  • Alkeon Capital Management added most to Sony in Q1 2022, an estimated $614M increase.
  • Alkeon Capital Management's biggest Q1 2022 reduction was Alibaba, cutting an estimated $265M.
  • Alkeon Capital Management fully exited Anaplan, Inc. in Q1 2022, selling an estimated $201M.
  • Alkeon Capital Management's ten largest holdings make up 51% of its $49.9B portfolio in Q1 2022.
  • Alkeon Capital Management opened 17 new positions and closed 24 in Q1 2022.
  • Alkeon Capital Management's portfolio value fell 7.6% quarter-over-quarter to $49.9B.

Based on Alkeon Capital Management's 13F filing for Q1 2022, filed 16 May 2022.